Award Winners

The ISPOR Research Presentation Podium and Poster Awards were established in 1998 to recognize the scientific merit of podium and poster presentations at ISPOR’s conferences.

ISPOR Judges evaluated podium and poster presentations within the top 5% of accepted abstracts, which were based on abstract peer reviewed scores, and were eligible for a presentation award.

Evaluations of scientific merit were based upon the following criteria:


  • Research design is appropriate and transparent
  • Data sources are appropriate and transparent
  • Data analyses are appropriate and transparent
  • Results are included and are transparent and comprehensible
  • Uncertainty of results is addressed appropriately
  • Conclusions are consistent with the results


  • Objectives/research questions are clearly stated, and objectives are addressed
  • Factual information is kept separate from interpretations or implications / unbiased presentations
  • Implications, as presented, are easy to understand
  • Clarity of presentation



HPR131: What Is a Year of Life Worth? Empirical Findings from Worldwide Economic Studies on the Value of a Statistical Life

Presenting Author: Ramon Schaefer, German Cancer Research Center (DKFZ), Germany


HPR181: Comprehensive and Standardized Value Assessment of Innovative Cancer Treatments: A Multi-Criteria Decision Analysis (MCDA) Tool for Switzerland

Presenting Author: Florian Kuhlmey, Polynomics SA, Switzerland


PT27: How Much Does TLV Value Rarity? A Review of Reimbursement Decisions on Orphan Drugs in Sweden from 2017 through 2022

Presenting Author: Maria Kinderas, RTI Health Solutions, United Kingdom



EE701: Cost-Effectiveness Analysis of Polatuzumab Vedotin Combined with Chemoimmunotherapy in Untreated Diffuse Large B-Cell Lymphoma (DLBCL) in China

Presenting Author: Xiaoning He, Tianjin University, China


EPH11: Prevalence, Risk Factors, and Characterization of Individuals with Long COVID Using Electronic Health Records in Over 1.5 Million COVID Cases in England

Presenting Author: Han-I Wang, University of York, United Kingdom


PT48: International Reference Pricing Analysis of Medicines in Turkiye By 2022

Presenting Author: Selin Okcun, ECONiX Research, Turkey



HTA237: Treatment Effect Waning in Immuno-Oncology Health Technology Assessments: A Review of Assumptions and Supporting Evidence

Presenting Author: Kurt Taylor, Delta Hat Limited, United Kingdom


PT4: Patient-Reported Outcomes (PROs) in German AMNOG-Assessments: Impact of Increasing the Response Threshold to 15 %

Presenting Author: Susan Fischer-Huchzermeyer, Xcenda GmbH, part of Cencora, Germany


RWD50: Evaluation and Improvement of a NHDS Algorithm to Detect Patients With Metastatic Breast Cancer and HER2+ Status Using a RWE NLP-Powered Solution

Presenting Author: Marc Jouve, Sancare, France



P3: Open-Source Model Framework for Health-Economic Evaluation of Early Treatment in Alzheimer's Disease

Presenting Author: Ron Handels, Maastricht University, Netherlands


P12: Screen-Detected Breast Cancers Have Improved 5-Year Disease Free Interval Compared to Interval and Non-Screen-Related Breast Cancer, Taking Lead Time into Account

Presenting Author: Anouk Eijkelboom, Netherlands Comprehensive Cancer Organisation (IKNL), Netherlands


P31: Evidence Supporting Regulatory Withdrawals and Quantifying Their Impact on Public Health

Presenting Author: Samantha Lane, Drug Safety Research Unit, United Kingdom



P15: Unraveling Acceptance of Healthcare Innovations in Neurorehabilitation: A Systematic Approach Through Health Preference Research

Presenting Author: Ann-Kathrin Fischer, Hochschule Neubrandenburg, Germany


P17: A Retrospective Analysis of Medicare Current Beneficiary Survey Data to Evaluate the Alzheimer's Disease and Related Dementia Risk-Reducing Benefits Offered By HMGCR Inhibitors or Statins

Presenting Author: Mohin Chanpura, Rutgers University, USA


P32: Implementation of Early Access Reform in France and Access to Innovation: Impact in Terms of Number of Drugs, Patients Treated, and Cost

Presenting Author: Tess Martin, Paris Saclay University, France



P9: Impact of Organized Colorectal Cancer Screening on Age-Specific Population Incidences: Evidence from a Natural Experiment in Sweden

Presenting Author: Gabriella Chauca Strand, University of Gothenburg, Sweden


P36: Towards a Collaborative Value Assessment Framework for Provider-Facing Digital Health Technologies Used in Chronic Disease Management: Findings and Implications

Presenting Author: Caitlin Main, London School of Economics and Political Science, United Kingdom


P48: New NICE Proportionate Approaches: Are They Any Faster or More Successful?

Presenting Author: Rebecca Andrews, PRECISIONadvisors, United Kingdom



Presentation Award Judge Acknowledgment

ISPOR would like to thank the ISPOR Europe 2023 judges who have volunteered their time and expertise in judging the podium and poster presentations.

Claire Ainsworth, MSc, United Kingdom

Omar Albalawi, Master, Saudi Arabia

Patricia Aluko, MSc, United Kingdom

Carlos Alves, PhD, Portugal

Daniel Ankrah, MSc, PhD, Ghana

Kagan Atikeler, MPharm, Turkey

Bander Balkhi, PharmD, PhD, Saudi Arabia

Richard Ballerand, MA, United Kingdom

Murtuza Bharmal, MS, PhD, USA

Ash Bullement, MSc, United Kingdom

Isaac Corro Ramos, PhD, Netherlands

Paolo Cortesi, PhD, Italy

Diederik De Cock, PhD, Belgium

Rossella Di Bidino, PhD, Italy

Sean Gavan, PhD, MSc, United Kingdom

Gianni Ghetti, MA, Italy

George Gourzoulidis, MSc, Greece

Juan Gualda Gea, MSc, Spain

Sabera Hashim, MSc, United Kingdom

Niall Hatchell, MSc, United Kingdom

Brooke Hayward Ro, SM, MBA, USA

Remon Helmy, MSc, PhD, MBA, Switzerland

Tove Holm-Larsen, MSc, PhD, Denmark

Mireia Jofre-Bonet, PhD, United Kingdom

K Ian Johnson, MBPS, SRPharmS, United Kingdom

Christin Juhnke, MA, Germany

Mariya Kamusheva, MPh, PhD, Bulgaria

Irem Karaomerlioglu, Doctorate, Turkey

Kirandeep Kaur, MBBS MD (Pharmacology), India

Sandeep Kiri, MSc, United Kingdom

Guvenc Kockaya, MD, MSc, PhD, Turkey

Alexander Kostyuk, MD, PhD, Kazakhstan

Jinender Kumar, MS, USA

Betsy Lahue, MPH, USA

Bryony Langford, MSc, MPhil, United Kingdom

Ka Keat Lim, MPharm, MSc, PhD, United Kingdom

Lorena Lopez-Gonzalez, PhD, USA

Andrea Marcellusi, PhD, Italy

Stuart Mealing, MSc, United Kingdom

Andrew Mumford, United Kingdom

Siyabonga Ndwandwe, MSc, United Kingdom

Liv Nymark, PhD, Denmark

Shinya Ohno, PhD, MPH, Japan

Riku Ota, MPH, Japan

Hannah Patrick, FFPHM, United Kingdom

Massimiliano Povero, PhD, Italy

Nan Qiao, PhD, MPH, MSc, MBBS, USA

Mahendra Kumar Rai, PhD, Singapore

Sreeram Ramagopalan, PhD, United Kingdom

Ralitsa Raycheva, MEcon, PhD, Bulgaria

Syed Raza, MBA, MSc, United Kingdom

Jean- Francois Ricci, PharmD, MBA, PhD, Switzerland

Meg Richards, PhD, MPH, USA

Jessica Roydhouse, PhD, Australia

Naomi Sacks, PhD, USA

Khalid Salman, MD, Saudi Arabia

Vassiki Sanogo, PhD, USA

Julian Shepelev, MSc, United Kingdom

Nuno Silverio, PharmD, RPh, MBA, Portugal

Panos Stafylas, MD, MSc, PhD, Greece

Andrew Stankus, MBA, USA

Stephen Stefani, MD, Brazil

Elio Tanaka, MD, Brazil

Annushiah Vasan Thakumar, PhD, Singapore

Steffen Wahler, MD; MA, Germany

Xiaojun Wang, PhD, Singapore

Akira Yuasa, PhD, Japan

Olha Zaliska, Prof., PhD, DSci., Ukraine